Huikun Zhang
Overview
Explore the profile of Huikun Zhang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
226
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Guo Z, Zhang H, Liu X, Zhao Y, Chen Y, Jin J, et al.
J Exp Clin Cancer Res
. 2023 Feb;
42(1):49.
PMID: 36803413
Background: Metastasis of breast cancer grows from the local invasion to the distant colonization. Blocking the local invasion step would be promising for breast cancer treatment. Our present study demonstrated...
2.
Lan C, Zhang H, Wang K, Liu X, Zhao Y, Guo Z, et al.
Cell Death Dis
. 2022 Sep;
13(9):835.
PMID: 36171198
Intersectin 1 (ITSN1) contains two isoforms: ITSN1-S and ITSN1-L, which are highly regulated by alternative splicing. Our previous results showed that the two isoforms of ITSN1 displayed opposite functions: ITSN1-S...
3.
Chen P, Shao G, Li B, Zhang H, Xiao J, Zhao S
Sci Rep
. 2022 Aug;
12(1):13660.
PMID: 35953551
To assess the diagnostic ability of abbreviated protocols of MRI (AP-MRI) compared with unenhanced MRI (UE-MRI) in mammographically occult cancers in patients with dense breast tissue. The retrospective analysis consisted...
4.
Liu X, Zhang H, Zhao Y, Ma Y
Neuroscience
. 2022 Aug;
500:95-105.
PMID: 35952993
Glioblastoma is the most common primary brain tumor with poor survival rate and without effective treatment strategy. However, the influence of Girdin on human glioblastoma and the underlying molecular mechanisms...
5.
Zhou J, Chen H, Chen J, Wan D, Zhang H, Wang R, et al.
J Phys Chem A
. 2022 May;
126(20):3210-3218.
PMID: 35549278
2,6-Di--butyl-hydroxytotulene (BHT) is a widely used antioxidant in various fields. In this study, we explored comprehensively the mechanisms and kinetics of BHT degradation to produce isobutene using the density functional...
6.
Wang Z, Chong W, Zhang H, Liu X, Zhao Y, Guo Z, et al.
Front Cell Dev Biol
. 2022 Apr;
10:784920.
PMID: 35445014
Increasing studies have demonstrated lymph node ratio (LNR) to be an accurate prognostic indicator in breast cancer and an alternative to pN staging; however, the AJCC-TNM staging system classified apical...
7.
Zhang H, Zhao Y, Liu X, Fu L, Gu F, Ma Y
Front Oncol
. 2021 Oct;
11:724250.
PMID: 34631552
Background: Breast cancer is the most commonly diagnosed cancer worldwide. However, the well-known biomarkers are not enough to meet the needs of precision medicine. Novel targets are desirable and highly...
8.
Zhang H, Guo Z, Liu X, Zhao Y, Chen Y, Zhang M, et al.
Cell Death Dis
. 2021 Oct;
12(10):922.
PMID: 34625530
Breast cancer is the most common type of cancer worldwide. However, the well-known molecular biomarkers are not enough to meet the needs of precision medicine. In search for novel targets...
9.
Chong W, Zhang H, Guo Z, Yang L, Shao Y, Liu X, et al.
Cell Death Differ
. 2020 Aug;
28(1):382-400.
PMID: 32814878
Anthracyclines are a class of conventional and commonly used frontline chemotherapy drugs to treat breast cancer. However, the anthracycline-based regimens can only reduce breast cancer mortality by 20-30%. Furthermore, there...
10.
Zhang H, Ericksen S, Lee C, Ananiev G, Wlodarchak N, Yu P, et al.
PLoS Comput Biol
. 2019 Aug;
15(8):e1006813.
PMID: 31381559
Prediction of compounds that are active against a desired biological target is a common step in drug discovery efforts. Virtual screening methods seek some active-enriched fraction of a library for...